Biomin GmbH; Filing of Food Additive Petition (Animal Use), 26902 [2020-09187]
Download as PDF
26902
Federal Register / Vol. 85, No. 88 / Wednesday, May 6, 2020 / Proposed Rules
and effective September 15, 2019, which
is incorporated by reference in 14 CFR
71.1. The Class E airspace designation
listed in this document will be
published subsequently in the Order.
FAA Order 7400.11, Airspace
Designations and Reporting Points, is
published yearly and effective on
September 15.
Regulatory Notices and Analyses
The FAA has determined that this
regulation only involves an established
body of technical regulations for which
frequent and routine amendments are
necessary to keep them operationally
current, is non-controversial and
unlikely to result in adverse or negative
comments. It, therefore: (1) Is not a
‘‘significant regulatory action’’ under
Executive Order 12866; (2) is not a
‘‘significant rule’’ under DOT
Regulatory Policies and Procedures (44
FR 11034; February 26, 1979); and (3)
does not warrant preparation of a
regulatory evaluation as the anticipated
impact is so minimal. Since this is a
routine matter that will only affect air
traffic procedures and air navigation, it
is certified that this rule, when
promulgated, would not have a
significant economic impact on a
substantial number of small entities
under the criteria of the Regulatory
Flexibility Act.
Environmental Review
This proposal will be subject to an
environmental analysis in accordance
with FAA Order 1050.1F,
‘‘Environmental Impacts: Policies and
Procedures’’ prior to any FAA final
regulatory action.
1. The authority citation for 14 CFR
part 71 continues to read as follows:
Authority: 49 U.S.C. 106(f), 106(g); 40103,
40113, 40120; E.O. 10854, 24 FR 9565, 3 CFR,
1959–1963 Comp., p. 389.
VerDate Sep<11>2014
21:25 May 05, 2020
Jkt 250001
*
*
*
Issued in Fort Worth, Texas, on April 27,
2020.
Steven Phillips,
Acting Manager, Operations Support Group,
ATO Central Service Center.
[FR Doc. 2020–09464 Filed 5–5–20; 8:45 am]
BILLING CODE 4910–13–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
21 CFR Part 573
[Docket No. FDA–2020–F–1275]
Biomin GmbH; Filing of Food Additive
Petition (Animal Use)
AGENCY:
Food and Drug Administration,
HHS.
The Food and Drug
Administration (FDA or we) is
announcing that we have filed a
petition, submitted by Biomin GmbH,
proposing that the food additive
regulations be amended to provide for
the safe use of fumonisin esterase to
degrade fumonisins present in swine
feed.
The food additive petition was
filed on March 26, 2020.
ADDRESSES: For access to the docket to
read background documents or
comments received, go to https://
www.regulations.gov and insert the
docket number found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts;
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT:
Carissa Adams, Center for Veterinary
Medicine, Food and Drug
Administration, 7519 Standish Pl.,
Rockville, MD 20855, 240–402–6283,
Carissa.Adams@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
Federal Food, Drug, and Cosmetic Act
DATES:
■
[Amended]
*
ACE MO E5 Sedalia, MO [Amended]
Sedalia Regional Airport, MO
(Lat. 38°42′27″ N, long. 93°10′33″ W)
That airspace extending upward from 700
feet above the surface within a 6.6-mile
radius of Sedalia Regional Airport.
SUMMARY:
PART 71—DESIGNATION OF CLASS A,
B, C, D, AND E AIRSPACE AREAS; AIR
TRAFFIC SERVICE ROUTES; AND
REPORTING POINTS
2. The incorporation by reference in
14 CFR 71.1 of FAA Order 7400.11D,
Airspace Designations and Reporting
Points, dated August 8, 2019, and
*
Notification; petition for
rulemaking.
The Proposed Amendment
Accordingly, pursuant to the
authority delegated to me, the Federal
Aviation Administration proposes to
amend 14 CFR part 71 as follows:
■
Paragraph 6005. Class E Airspace Areas
Extending Upward From 700 Feet or More
Above the Surface of the Earth
ACTION:
List of Subjects in 14 CFR Part 71
Airspace, Incorporation by reference,
Navigation (air).
§ 71.1
effective September 15, 2019, is
amended as follows:
PO 00000
Frm 00015
Fmt 4702
Sfmt 4702
(section 409(b)(5) (21 U.S.C. 348(b)(5))),
we are giving notice that we have filed
a food additive petition (FAP 2311)
submitted by Biomin GmbH; Erber
Campus 1, 3131 Getzersdorf, Austria.
The petition proposes to amend Title 21
of the Code of Federal Regulations (CFR)
in part 573 (21 CFR part 573) Food
Additives Permitted in Feed and
Drinking Water of Animals to provide
for the safe use of fumonisin esterase to
degrade fumonisins present in swine
feed.
The petitioner has claimed that this
action is categorically excluded under
21 CFR 25.32(r) because it is of a type
that does not individually or
cumulatively have a significant effect on
the human environment. In addition,
the petitioner has stated that, to their
knowledge, no extraordinary
circumstances exist. If FDA determines
a categorical exclusion applies, neither
an environmental assessment nor an
environmental impact statement is
required. If FDA determines a
categorical exclusion does not apply, we
will request an environmental
assessment and make it available for
public inspection.
Dated: April 24, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020–09187 Filed 5–5–20; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF THE INTERIOR
Bureau of Indian Affairs
25 CFR Part 82
[201A2100DD/AAKC001030/
A0A501010.999900 253G]
RIN 1076–AF51
Procedures for Federal
Acknowledgment of Alaska Native
Entities
Bureau of Indian Affairs,
Interior.
ACTION: Proposed rule; correction and
reopening of period for comments on
the information collection.
AGENCY:
The Bureau of Indian Affairs
published a proposed rule in the
Federal Register of January 2, 2020, that
contained errors in the Paperwork
Reduction Act statement. This
document provides a corrected
Paperwork Reduction Act statement and
reopens the comment period for
comments on the information collection
described in that statement.
SUMMARY:
E:\FR\FM\06MYP1.SGM
06MYP1
Agencies
[Federal Register Volume 85, Number 88 (Wednesday, May 6, 2020)]
[Proposed Rules]
[Page 26902]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-09187]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 573
[Docket No. FDA-2020-F-1275]
Biomin GmbH; Filing of Food Additive Petition (Animal Use)
AGENCY: Food and Drug Administration, HHS.
ACTION: Notification; petition for rulemaking.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or we) is announcing
that we have filed a petition, submitted by Biomin GmbH, proposing that
the food additive regulations be amended to provide for the safe use of
fumonisin esterase to degrade fumonisins present in swine feed.
DATES: The food additive petition was filed on March 26, 2020.
ADDRESSES: For access to the docket to read background documents or
comments received, go to https://www.regulations.gov and insert the
docket number found in brackets in the heading of this document, into
the ``Search'' box and follow the prompts; and/or go to the Dockets
Management Staff, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Carissa Adams, Center for Veterinary
Medicine, Food and Drug Administration, 7519 Standish Pl., Rockville,
MD 20855, 240-402-6283, [email protected].
SUPPLEMENTARY INFORMATION: Under the Federal Food, Drug, and Cosmetic
Act (section 409(b)(5) (21 U.S.C. 348(b)(5))), we are giving notice
that we have filed a food additive petition (FAP 2311) submitted by
Biomin GmbH; Erber Campus 1, 3131 Getzersdorf, Austria. The petition
proposes to amend Title 21 of the Code of Federal Regulations (CFR) in
part 573 (21 CFR part 573) Food Additives Permitted in Feed and
Drinking Water of Animals to provide for the safe use of fumonisin
esterase to degrade fumonisins present in swine feed.
The petitioner has claimed that this action is categorically
excluded under 21 CFR 25.32(r) because it is of a type that does not
individually or cumulatively have a significant effect on the human
environment. In addition, the petitioner has stated that, to their
knowledge, no extraordinary circumstances exist. If FDA determines a
categorical exclusion applies, neither an environmental assessment nor
an environmental impact statement is required. If FDA determines a
categorical exclusion does not apply, we will request an environmental
assessment and make it available for public inspection.
Dated: April 24, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020-09187 Filed 5-5-20; 8:45 am]
BILLING CODE 4164-01-P